Find a MS Trial
Efficacy and Safety of Ofatumumab and Siponimod Compared to Fingolimod in Pediatric Patients With Multiple Sclerosis (NEOS)
September 15, 2023
Location: Rest of the World, VIC
Type of study/intervention: Randomized, 3-arm, Double-blind, Non-inferiority Study followed by an Open-label Extension
Recruitment Status: Recruiting
Form of MS: Relapsing MS, Relapsing remitting MS
Location: NSW
Type of study/intervention: Observational/ Non-interventional
Recruitment Status: Recruiting
Form of MS: Clinically isolated syndrome, Primary progressive MS, Relapsing MS, Relapsing remitting MS, Secondary progressive MS
Location: ACT, NSW, NT, QLD, SA, TAS, VIC, WA
Type of study/intervention: Non-interventional (on-line survey, optional focus group)
Recruitment Status: Recruiting
Form of MS: Primary progressive MS, Relapsing MS, Relapsing remitting MS, Secondary progressive MS
Understanding the perspectives of people with physical disabilities on using sexual assistive devices
July 14, 2023
Location: ACT, NSW, NT, NZ, QLD, Rest of the World, SA, TAS, VIC, WA
Type of study/intervention: Allied Health
Recruitment Status: Recruiting
Form of MS: Clinically isolated syndrome, People with any form of MS, People without MS, Primary progressive MS, Relapsing remitting MS, Secondary progressive MS, Symptoms related to MS
Location: ACT, NSW, NT, NZ, QLD, SA, TAS, VIC, WA
Type of study/intervention: Device
Recruitment Status: Recruiting
Form of MS: Clinically isolated syndrome, Primary progressive MS, Relapsing MS, Relapsing remitting MS, Secondary progressive MS
Location: ACT, NSW, NT, QLD, SA, TAS, VIC, WA
Type of study/intervention: Allied Health/ Non-interventional
Recruitment Status: Recruiting
Form of MS: Primary progressive MS, Relapsing MS, Relapsing remitting MS, Secondary progressive MS
